An open-label pilot study of vemurafenib in previously treated metastatic melanoma patients with brain metastases.

被引：16
|
作者：
Dummer, R.
Rinderknecht, J.
Goldinger, S. M.
Wagner, I.
Mitchell, L.
Veronese, M. L.
Nick, S.
Hilfiker, P.
Gobbi, S.
机构：
[1] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[2] F Hoffmann La Roche, Basel, Switzerland
[3] F Hoffmann La Roche, Reinach, Switzerland
[4] MRI Bethanien, Zurich, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.8548
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8548
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics
    Papoutsaki, Marina
    Chimenti, Maria-Sole
    Costanzo, Antonio
    Talamonti, Marina
    Zangrilli, Arianna
    Giunta, Alessandro
    Bianchi, Luca
    Chimenti, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (02) : 269 - 275
  • [42] Regorafenib for previously treated metastatic colorectal cancer (mCRC): Results from 683 Italian patients treated in the open-label phase 3B CONSIGN study
    Ciardiello, F.
    Falcone, A.
    Cascinu, S.
    Sobrero, A.
    Boni, C.
    Barone, C.
    Luppi, G.
    Maiello, E.
    Siena, S.
    Zagonel, V.
    Carteni, G.
    Di Constanzo, F.
    Di Bartolomeo, M.
    Santoro, A.
    Russo, A.
    Moscovici, M.
    Van Cutsem, E.
    Zaniboni, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S380 - S381
  • [43] Regorafenib for previously treated metastatic colorectal cancer (mCRC): A subgroup analysis of 364 patients in the USA treated in the international, open-label phase IIIb CONSIGN study.
    Verma, Udit
    Arriaga, Yull Edwin
    Lenz, Heinz-Josef
    Henderson, Charles A.
    Fuloria, Jyotsna
    Cartwright, Thomas H.
    Khojasteh, Ali
    Stella, Philip J.
    Saltzman, Marc
    Cohn, Allen Lee
    Philip, Philip Agop
    Kappeler, Christian
    Kalmus, Joachim
    Grothey, Axel
    Van Cutsem, Eric
    Hochster, Howard S.
    Arena, Francis P.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [44] Phase 2, Open-Label Study of EZN-2208 (PEG-SN38) in Patients with Previously Treated Metastatic Breast Cancer.
    O'Shaughnessy, J. A.
    Osbome, C. R. C.
    Steinberg, M. A.
    Holmes, F. A.
    Kim, H. S.
    Kocs, D. M.
    Richards, P. D.
    Vukelja, S. J.
    Berkowitz, N.
    Buchbinder, A.
    CANCER RESEARCH, 2011, 71
  • [45] Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit
    Montaudie, Henri
    Cerezo, Michael
    Bahadoran, Philippe
    Roger, Coralie
    Passeron, Thierry
    Machet, Laurent
    Arnault, Jean-Philippe
    Verneuil, Laurence
    Maubec, Eve
    Aubin, Francois
    Granel, Florence
    Giacchero, Damien
    Hofman, Veronique
    Lacour, Jean-Philippe
    Maryline, Allegra
    Ballotti, Robert
    Rocchi, Stephane
    PIGMENT CELL & MELANOMA RESEARCH, 2017, 30 (03) : 378 - 380
  • [46] Results from the large, open-label phase 3b CONSIGN study of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC)
    Van Cutsem, E.
    Ciardiello, F.
    Seitz, J. -F.
    Hofheinz, R. D.
    Verma, U.
    Garcia-Carbonero, R.
    Grothey, A.
    Miriyala, A.
    Kalmus, J.
    Shapiro, J.
    Falcone, A.
    Zaniboni, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 42 - 42
  • [47] Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma
    Homsi, Jade
    Bedikian, Agop Y.
    Papadopoulos, Nicholas E.
    Kim, Kevin B.
    Hwu, Wen-Jen
    Mahoney, Sandy L.
    Hwu, Patrick
    MELANOMA RESEARCH, 2010, 20 (06) : 507 - 510
  • [48] Patients with metastatic melanoma treated with vemurafenib as monotherapy or in combination with cobimetinib.
    Ocvirk, Janja
    Rebersek, Martina
    Boc, Marko
    Mesti, Tanja
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Sarcoidosis in Patients Treated with Vemurafenib for Metastatic Melanoma: A Paradoxical Autoimmune Activation
    Lheure, Coralie
    Kramkimel, Nora
    Franck, Nathalie
    Laurent-Roussel, Sara
    Carlotti, Agnes
    Queant, Astrid
    Goldwasser, Francois
    Avril, Marie-Francoise
    Dupin, Nicolas
    DERMATOLOGY, 2015, 231 (04) : 378 - 384
  • [50] Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia
    Rosenthal, MH
    Bryant, S
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 301 - 301
12345